Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Debt / NOTE 0.125%12/1
-
Number of holders
-
15
-
Total 13F principal, excl. options
-
44,639,000
-
Principal change
-
-68,175,000
-
Total reported value, excl. options
-
$42,503,289
-
Value change
-
-$63,789,292
-
Number of buys
-
2
-
Number of sells
-
17
-
Price
-
$0.9513
Institutional Holders of IONIS PHARMACEUTICALS INC - NOTE 0.125%12/1 as of Q3 2023
As of 30 Sep 2023 IONIS PHARMACEUTICALS INC - NOTE 0.125%12/1 had 15 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $44,639,000 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included Sonora Investment Management Group, LLC, MORGAN STANLEY, MACQUARIE GROUP LTD, Penn Mutual Asset Management, LLC, PALISADE CAPITAL MANAGEMENT, LP, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main, HighTower Advisors, LLC, CITIGROUP INC, WELLS FARGO & COMPANY/MN, and Kohlberg Kravis Roberts & Co. L.P..
This table shows 15 bond principal holders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.